The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6257-6266

  Marchetti, Philippe ^a   Zamzami, Naoufal ^b   Joseph, Bertrand ^a   Schraen Maschke, Susanna ^a   Méreau Richard, Claude ^a   Costantini, Paola ^b   Métivier, Didier ^b   Susin, Santos A ^b   Kroemer, Guido ^b   Formstecher, Pierre ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CASPASE; CYCLOSPORIN A; CYTOCHROME C OXIDASE; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL NUCLEUS; CHROMATIN CONDENSATION; CONTROLLED STUDY; ENZYME RELEASE; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CELL NUCLEUS; CELL-FREE SYSTEM; CYTOPLASM; ENDOPLASMIC RETICULUM; FLAVOPROTEINS; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, RETINOIC ACID; RETINOIDS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 17144448793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Rogers, M. B. Life-and-death decisions influenced by retinoids. Curr. Top. Dev. Biol., 35: 1-46, 1997.
2. Lotan, R. Retinoids in cancer chemoprevention. FASEB J., 10: 1031-1039, 1996.
3. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
4. Takeshita, A., Shibata, Y., Shinjo, K., Yanagi, M,. Tobita, T., Ohnishi, K., Miyawaki, S., Shudo, K., and Ohno, R. Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80. Ann. Intern. Med., 124: 893-896, 1996.
5. Bernard, B. A., Bernardon, J. M., Delescluse, C., Martin, B., Lenoir, M. C., Maignan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun , 186: 977-983, 1992.
6. Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., von Stebut, E., Worm, M., Makki, A., Jurgovsky, K., Kolde, G., and Henz, B. M. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-2 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol., 135: 1889-1898, 1996.
7. Schadendorf, D., Worm, M. Jurgovsky, K., Dippel, E., Michel, S., Charpentier, B., Bernardon, J-M., Reichert, U., and Czarnetzki, B. M. Retinoic acid receptor-γ-selective retinoids exert antiproliferative effects on human melanoma cell growth in vitro. Int. J. Oncol., 5: 1325-1331, 1994.
8. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene, 11: 493-504, 1995.
9. Chao, W. R., Hobbs, P. D., Jong, L., Zhang, X. K., Zheng, Y., Wu, Q., Shroot, B., and Dawson, M. I. Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH: OVCAR-3 ovarian cancer cell line in culture. Cancer Lett., 115: 1-7, 1997.
10. Langdon, S. P., Rabiasz, G. J., Ritchie, A. A., Reichert, U., Buchan, P., Miller, W. R., and Smyth, J. F. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo. Cancer Chemother. Pharmacol., 42: 429-432, 1998.
11. Oridate, N., Higuchi, M., Suzuki, S., Shroot, B., Hong, W. K., and Lotan, R. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphtalene carboxylic acid (CD437). Int. J. Cancer, 70: 484-487, 1997.
12. Adachi, H., Preston, G., Harvat, B., Dawson, M. I., and Jetten, A. M. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am. J. Respir. Cell Mol. Biol., 18: 323-333, 1998.
13. Sun, S. Y., Yue, P., Dawson, M. I., Shroot, B., Michel, S., Lamph, W. W., Heyman, R. A., Teng, M., Chandraratna, R. A., Shudo, K., Hong, W. K., and Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Rev., 57: 4931-4939, 1997.
14. Sun, S. Y., Yue, P., Shroot, B., Hong, W. K., and Lotan, R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J. Cell Physiol., 173: 279-284, 1997.
15. Meister, B., Fink, F. M., Hittmair, A., Marth, C., and Widschwendter, M. Antiproliferative activity and apoptosis induced by retinoic acid receptor-γ selectively binding retinoids in neuroblastoma. Anticancer Res., 18: 1777-1786, 1998.
16. Liang, J. Y., Fontana, J. A., Rao, J. N., Ordonez, J. V., Dawson, M. I., Shroot, B., Wilber, J. F., and Feng, P. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3. Prostate, 38: 228-236, 1999.
17. Hsu, C. A., Rishi, A. K., Su-Li, X., Gerald, T. M., Dawson, M. I., Schiffer, C., Reichert, U., Shroot, B., Poirer, G. C., and Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood, 89: 4470-4479, 1997.
18. Adachi, H., Adams, A., Hughes, F. M., Zhang, J., Cidlowski, J. A., and Jetten, A. M. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways. Cell Death Differ., 5: 973-983, 1998.
19. Mologni, L., Ponzanelli, I., Bresciani, F., Sardiello, G., Bergamaschi, D., Gianni, M., Reichert, U., Rambaldi, A., Terao, M., and Garattini, E. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood, 93: 1045-1061, 1999.
20. Lu, X. P., Fanjul, A., Picard, N., Pfahl, M., Rungta, D., Nared-Hood, K., Carter, B., Piedrafita, J., Tang, S., Fabbrizio, E., and Pfahl, M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med., 3: 686-690, 1997.
21. Fanjul, A., Piedrafita, F., Al-Shamma, H., and Pfahl, M. Apoptosis induction and potent antioestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist. Cancer Res., 58: 4607-4610, 1998.
22. Widschwendter, M., Daxenbichler, G., Culig, Z,. Michel, S., Zeimet, A. G., Mortl, M. G., Widschwendter, A., and Marth, C. Activity of retinoic acid receptor-γ selectively binding retinoids alone and in combination with interferon-γ in breast cancer cell lines. Int. J. Cancer, 71: 497-504, 1997.
23. L fails to inhibit apoptosis mediated by a novel retinoid. Oncol. Res., 10: 313-324, 1998.
24. Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M. I., Reed, J. C., Fontana, J. A., Bost, F., Hobbs, P. D., Zheng, Y., Chen, G. Q., Shroot, B., Mercola, D., and Zhang, X. K. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol. Cell. Biol., 18: 4719-4731, 1998.
25. WAF1/CIP1 expression in human breast carcinoma cells. Cancer Res., 56: 5055-5062, 1996.
26. Sun, S. Y., Yuc, P., Wu, G. S., El-Deiry, W. S., Shroot, B., Hong, W. K., and Lotan, R. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene, 18: 2357-2365, 1999.
27. L expression and its downregulation by a novel retinoid in breast carcinoma cells. Exp. Cell Res., 232: 17-24, 1997.
28. Piedrafita, F. J., and Pfahl, M. Retinoid-induced apoptosis and SpI cleavage occur independently of transcription and require caspase activation. Mol. Cell. Biol., 17: 6348-6358, 1997.
29. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
30. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D. R., Aebersold, R., Siderovski, D. P., Penninger, J. M., and Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (Lond.), 397: 441-446, 1999.
31. Kroemer, G., Zamzami, N., and Susin, S. Mitochondrial control of apoptosis. Immunol. Today, 18: 44-51, 1997.
32. Marzo, I., Brenner, C., Zamzami, N., Jurgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prevost, M. C., Xie, Z. H., Matsuyama, S., Reed, J. C., and Kroemer, G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (Washington DC), 281: 2027-2031, 1998.
33. Zoratti, M., and Szabo, I. The mitochondrial permeability transition. Biochim. Biophys. Acta., 1241: 139-176, 1995.
34. Eriksson, O., Fontaine, E., and Bernardi, P. Chemical modification of arginines by 2,3-butanedione and phenylglyoxal causes closure of the mitochondrial permeability transition pore. J. Biol. Chem., 15: 12669-12674, 1998.
35. Hoyt, K., Sharma, T., and Reynolds, I. Trifluoperazine and dibucaine-induced inhibition of glutamate-induced mitochondrial depolarization in rat cultured forebrain neurones. Br. J. Pharmacol., 122: 803-808, 1997.
36. Elimadi, A., Bouillot, L., Sapena, R., Tillement, J., and Morin, D. Dose-related inversion of cinnarizine and flunarizine effects on mitochondrial permeability transition. Eur. J. Pharmacol., 348: 115-121, 1998.
37. Elimadi, A., Settaf, A., Morin, D., Sapena, R., Lamchouri, F., Cherrah, Y., and Tillement, J. Trimetazidine counteracts the hepatic injury associated with ischemiareperfusion by preserving mitochondrial function. J. Pharmacol. Exp. Ther., 286: 23-28, 1998.
38. Friberg, H., Ferrand-Drake, M., Bengtsson, F., Halestrap, A. P., and Wieloch, T. Cyctosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci., 18: 5151-5159, 1998.
39. Zamzami, N., Marchetti, P., Castedo, M., Hirsch, T., Susin, S., Masse, B., and Kroemer, G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett., 384: 53-57, 1996.
40. Marchetti, P., Castedo, M., Susin, S., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroemer, G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med., 184: 1155-1160, 1996.
41. Marchetti, P., Decaudin, D., Macho, A., Zamzami, N., Hirsch, T., Susin, S., and Kroemer, G. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur. J. Immunol., 27: 289-296, 1997.
42. Joseph, B., Lefebvre, O., Mereau-Richard, C., Danze, P. M., Belin-Plancot, M. T., and Formstecher, P. Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226. Blood, 91: 2423-2432, 1998.
43. Zhu, W., Cowie, A., Wasfy, G. W., Penn, L. Z., Leber, B., and Andrews, D. W. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J., 15: 4130-4141, 1996.
44. Jacobson, M., Burne, J., and Raff, M. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
45. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S., Petit, P., Mignotte, B., and Kroemer, G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med., 182: 367-377, 1995.
46. Kawabe, Y., and Ochi, A. Programmed cell death and extrathymic reduction of Vb8+ CD4+ T cells in mice tolerant to Staphylococcus aureus anterotoxin B. Nature (Lond.), 245-248, 1991.
47. Boutry, M., and Briquet, M. Mitochondrial modifications associated with the cytoplasmic male sterility in faba beans. Eur. J. Biochem., 129-135, 1982.
48. Petronilli, V., Cola, C., Massari, S., Colonna, R., and Bernardi, P. Physiological effectors modify voltage-sensing by the cyclosporin A-sensitive mitochondrial permeability transition pore. J. Biol. Chem., 21939-21945, 1993.
49. Yasugi, E., Nakata, K., Yokoyama, Y., Kano, K., Dohi, T., and Oshima, M. Dihydroheptaprenyl and dihydrodecaprenyl monophosphates induce apoptosis mediated by activation of caspase-3-like protease. Biochim. Biophys. Acta, 1389: 132-140, 1998.
50. Mitamura, S., Ikawa, H., Mizuno, N., Kaziro, Y., and Itoh, H. Cytosolic nuclease activated by caspase-3 and inhibited by DFF-45. Biochem. Biophys. Res. Commun., 243: 480-484, 1998.
51. Wood, E. R., and Earnshaw, W. C. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J. Cell Biol., 2839-2850, 1990.
52. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol., 148: 2207-2216, 1992.
53. Hirsch, T., Marzo, I., and Kroemer, G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci. Rep., 17: 67-76, 1997.
54. Lazebnik, Y. A., Cole, S., Cooke, C. A., Nelson, W. G., and Earnshaw, W. C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol, 123: 7-22, 1993.
55. Evan, G. I., Wyllie, A., Gilbert, C., Littlewood, T., Land, H., Brooks, M., Waters, C., Penn, L., and Hancok, D. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
56. Yarovoi, S. V., Lu, X. P., Picard, N., Rungta, D., Rideout, D., and Pfahl, M. Selective activation of an apoptotic retinoid precursor in macrophage cell lines. J. Biol. Chem., 273: 20852-20859, 1998.
57. Kluck, R., Bossy-Wetzel, E., Green, D., and Newmeyer, D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Washington DC), 275: 1132-1136, 1997.
58. Mancini, M., Nicholson, D. W., Roy, S., Thornberry, N. A., Peterson, E. P., Casciola-Rosen, L. A., and Rosen, A. The caspase-3 precursor has a cytosolic and mitochondrial distribution; implications for apoptotic signaling. J. Cell Biol., 140: 1485-1495, 1998.
59. Adams, J. M., and Cory, S. The bcl-2 protein family: arbiters of cell survival. Science (Washington DC), 281: 1322-1326, 1998.
60. Krueger, K. E. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim. Biophys. Acta. 1241: 453-470, 1995.
61. Hirsch, T., Decaudin, D., Susin, S. A., Marchetti, P., Larochette, N., Resche-Rigon, M., and Kroemer, G. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res., 241: 426-434, 1998.
62. Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., and Debatin, K. M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem., 273: 33942-33948, 1998.
63. Szondy, Z., Reichert, U., Bernardon, J. M., Michel, S., Toth, R., Ancian, P., Ajzner, E., and Fesus, L. Induction of apoptosis by retinoids and retinoic acid receptor γ-selective compounds in mouse thymocytes through a novel apoptosis pathway. Mol. Pharmacol., 51: 972-982, 1997.